EXPERIENCE OF IMPLEMENTATION OF MODERN TREATMENT STANDARDS OF MULTIPLE/EXTENSIVE DRUG RESISTANT TUBERCULOSIS

by E. M. Zhukova, E. P. Myshkova
Published 2019-07-01

ANALYSIS OF THE PATIENTS REFERRED FOR TREATMENT TO NOVOSIBIRSK TUBERCULOSIS RESEARCH INSTITUTE FROM THE AREAS SUPERVISED BY THIS INSTITUTE. CHANGES IN CHEMOTHERAPY EFFICIENCY AFTER...

by E. P. Myshkova, E. M. Zhukova, T. A. Reykhrud
Published 2017-09-01

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG

by E. M. Zhukova, L. G. Vokhminova, D. A. Kudlay
Published 2019-12-01

INTEGRATED ASSESSMENT OF BRONCHIAL PATENCY IN ACTIVE PULMONARY TUBERCULOSIS TREATMENT BEFORE AND AFTER THE IN-PATIENT TREATMENT

by E. M. Zhukova, V. A. Krasnov, L. G. Vokhminova
Published 2015-08-01

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS

by E. M. Zhukova, T. A. Kolpakova, E. P. Myshkova, T. A. Reykhrud
Published 2016-10-01

Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis

by E. P. Myshkova, S. V. Sklyuev, E. M. Zhukova, D. V. Krasnov, T. I. Petrenko
Published 2020-08-01

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis

by N. V. Stavitskaya, I. G. Felker, E. M. Zhukova, А. I. Tlif, N. P. Doktorova, D. А. Kudlay
Published 2020-08-01